tocainide medication
妥卡尼藥物
tocainide therapy
妥卡尼療法
taking tocainide
服用妥卡尼
prescribed tocainide
處方妥卡尼
tocainide hydrochloride
妥卡尼鹽酸鹽
tocainide use
妥卡尼使用
tocainide treatment
妥卡尼治療
tocainide dosage
妥卡尼劑量
discontinuing tocainide
停止使用妥卡尼
tocainide effects
妥卡尼效果
tocainides are commonly prescribed for ventricular arrhythmias.
妥卡尼常用于治療心室性心律不整。
the physician adjusted the tocainides dosage based on the patient's response to treatment.
醫生根據患者對治療的反應調整了妥卡尼的劑量。
tocainides may cause dizziness and nausea as common side effects during initial treatment.
妥卡尼在初始治療期間可能引起暈眩和噁心等常見副作用。
regular blood monitoring is essential when administering tocainides to maintain therapeutic levels.
在使用妥卡尼時，定期血液監測對於維持治療濃度至關重要。
tocainides should not be combined with other sodium channel blocking antiarrhythmic drugs.
妥卡尼不可與其他鈉通道阻斷型抗心律不整藥物合併使用。
the clinical efficacy of tocainides has been demonstrated in multiple randomized trials.
妥卡尼的臨床療效已在多項隨機試驗中得到證實。
patients should immediately report any adverse cardiac reactions while taking tocainides.
患者在服用妥卡尼期間應立即報告任何不良心臟反應。
tocainides require careful dose titration to achieve optimal antiarrhythmic effects.
妥卡尼需要仔細調整劑量以達到最佳的抗心律不整效果。
the mechanism of action of tocainides involves selective sodium channel blockade in cardiac tissue.
妥卡尼的作用機制涉及在心臟組織中選擇性地阻斷鈉通道。
tocainides offer an effective oral alternative for patients who cannot tolerate intravenous lidocaine.
妥卡尼為無法耐受靜脈注射利多卡因的患者提供了一種有效的口服替代方案。
long-term tocainides therapy necessitates periodic electrocardiogram and liver function monitoring.
長期使用妥卡尼需要定期進行心電圖和肝功能監測。
tocainides metabolism occurs primarily through hepatic pathways with renal excretion of metabolites.
妥卡尼的代謝主要通過肝臟途徑進行，其代謝物則通過腎臟排出。
the safety profile of tocainides requires careful patient selection and monitoring protocols.
妥卡尼的安全性特徵需要仔細的患者選擇和監測方案。
tocainide medication
妥卡尼藥物
tocainide therapy
妥卡尼療法
taking tocainide
服用妥卡尼
prescribed tocainide
處方妥卡尼
tocainide hydrochloride
妥卡尼鹽酸鹽
tocainide use
妥卡尼使用
tocainide treatment
妥卡尼治療
tocainide dosage
妥卡尼劑量
discontinuing tocainide
停止使用妥卡尼
tocainide effects
妥卡尼效果
tocainides are commonly prescribed for ventricular arrhythmias.
妥卡尼常用于治療心室性心律不整。
the physician adjusted the tocainides dosage based on the patient's response to treatment.
醫生根據患者對治療的反應調整了妥卡尼的劑量。
tocainides may cause dizziness and nausea as common side effects during initial treatment.
妥卡尼在初始治療期間可能引起暈眩和噁心等常見副作用。
regular blood monitoring is essential when administering tocainides to maintain therapeutic levels.
在使用妥卡尼時，定期血液監測對於維持治療濃度至關重要。
tocainides should not be combined with other sodium channel blocking antiarrhythmic drugs.
妥卡尼不可與其他鈉通道阻斷型抗心律不整藥物合併使用。
the clinical efficacy of tocainides has been demonstrated in multiple randomized trials.
妥卡尼的臨床療效已在多項隨機試驗中得到證實。
patients should immediately report any adverse cardiac reactions while taking tocainides.
患者在服用妥卡尼期間應立即報告任何不良心臟反應。
tocainides require careful dose titration to achieve optimal antiarrhythmic effects.
妥卡尼需要仔細調整劑量以達到最佳的抗心律不整效果。
the mechanism of action of tocainides involves selective sodium channel blockade in cardiac tissue.
妥卡尼的作用機制涉及在心臟組織中選擇性地阻斷鈉通道。
tocainides offer an effective oral alternative for patients who cannot tolerate intravenous lidocaine.
妥卡尼為無法耐受靜脈注射利多卡因的患者提供了一種有效的口服替代方案。
long-term tocainides therapy necessitates periodic electrocardiogram and liver function monitoring.
長期使用妥卡尼需要定期進行心電圖和肝功能監測。
tocainides metabolism occurs primarily through hepatic pathways with renal excretion of metabolites.
妥卡尼的代謝主要通過肝臟途徑進行，其代謝物則通過腎臟排出。
the safety profile of tocainides requires careful patient selection and monitoring protocols.
妥卡尼的安全性特徵需要仔細的患者選擇和監測方案。
探索常見搜尋詞彙